Insider Transactions in Q2 2025 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2025
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
52
-0.22%
|
$22,048
$424.69 P/Share
|
|
May 13
2025
|
Stuart A Arbuckle EVP, COO |
BUY
Grant, award, or other acquisition
|
Direct |
37,622
+27.22%
|
-
|
|
May 02
2025
|
Sangeeta N. Bhatia Director |
SELL
Open market or private sale
|
Direct |
400
-7.65%
|
$202,000
$505.86 P/Share
|
|
May 01
2025
|
Suketu Upadhyay Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,001
-29.84%
|
-
|
|
May 01
2025
|
Suketu Upadhyay Director |
BUY
Grant, award, or other acquisition
|
Direct |
796
+19.18%
|
-
|
|
May 01
2025
|
Jennifer Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
796
+31.66%
|
-
|
|
May 01
2025
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
398
+16.36%
|
-
|
|
May 01
2025
|
Diana Mckenzie Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,001
-30.97%
|
-
|
|
May 01
2025
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
796
+19.76%
|
-
|
|
May 01
2025
|
Lloyd Carney Director |
BUY
Grant, award, or other acquisition
|
Direct |
796
+10.06%
|
-
|
|
May 01
2025
|
Alan M Garber Director |
BUY
Grant, award, or other acquisition
|
Direct |
398
+5.47%
|
-
|
|
May 01
2025
|
Sangeeta N. Bhatia Director |
BUY
Grant, award, or other acquisition
|
Direct |
796
+13.21%
|
-
|